SQI Diagnostics Inc
SQD.CA
$0.01
Closing
0.00
1D
0.00
YTD
Market cap
$4.47M
52 week high
$0.06
52 week low
$0.01
Volume
65,000
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $3.99/month
Market cap
$4.47M
Analysts' Rating
-
Price Target (Mean)
-
Total Analysts
0
P/E
Operating Margin
-1398.43%
Beta
-0.42
Revenue Growth (Annual)
-
52 week high
$0.06
52 week low
$0.01
Div. Yield
%
EPS Annual Growth
0.00
Note on Purification and Zakat
- Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly).
- If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
- For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them.
Company Profile
SQI Diagnostics Inc. discovers, develops, and commercializes diagnostic testing for healthcare professionals, patients and consumers. The Company develops and manufactures respiratory health and precision medicine tests that run on structured query language (SQI) fully automated systems. Its tests enhance COVID-19 antibody monitoring, rapid acute lung injury testing, donor organ transplant informatics, and immunological protein and antibody testing. Its COVID-19 testing solutions include Rapid Mobile PCR Testing for COVID-19, Sofia SARS Antigen Fluorescent Immunoassay (FIA) and Sofia2 Flu+SARS Antigen Fluorescent Immunoassay (FIA). Its transplant diagnostics solutions include TORdx LUNG Test, which is a diagnostic that assesses the health of donor lungs, and Ex Vivo Lung Perfusion provides care for conditioning donor lungs suspected of injury prior to transplantation. It also offers surveillance testing such as Celiac Disease Screening Test and Rheumatoid Arthritis Test.
